AU5293293A - Methods and compositions for treatment of allergic disease - Google Patents
Methods and compositions for treatment of allergic diseaseInfo
- Publication number
- AU5293293A AU5293293A AU52932/93A AU5293293A AU5293293A AU 5293293 A AU5293293 A AU 5293293A AU 52932/93 A AU52932/93 A AU 52932/93A AU 5293293 A AU5293293 A AU 5293293A AU 5293293 A AU5293293 A AU 5293293A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- treatment
- methods
- allergic disease
- allergic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95223792A | 1992-09-28 | 1992-09-28 | |
US952237 | 1992-09-28 | ||
PCT/US1993/009201 WO1994007521A1 (en) | 1992-09-28 | 1993-09-28 | Methods and compositions for treatment of allergic disease |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5293293A true AU5293293A (en) | 1994-04-26 |
Family
ID=25492687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52932/93A Abandoned AU5293293A (en) | 1992-09-28 | 1993-09-28 | Methods and compositions for treatment of allergic disease |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5293293A (en) |
WO (1) | WO1994007521A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0782169A (en) * | 1993-09-13 | 1995-03-28 | Toray Ind Inc | Wound healing agent |
GB9501683D0 (en) * | 1995-01-27 | 1995-03-15 | Glaxo Group Ltd | Substances and their uses |
WO1997024325A1 (en) * | 1995-12-28 | 1997-07-10 | Takeda Chemical Industries, Ltd. | DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS |
EP0972043A1 (en) * | 1996-09-25 | 2000-01-19 | British Biotech Pharmaceuticals Limited | Human rantes mutants incapable of aggregate formation |
EP0974357A1 (en) * | 1998-07-16 | 2000-01-26 | Schering-Plough | Chemokines as adjuvants of immune response |
CA2469607A1 (en) * | 2001-12-13 | 2003-06-19 | Kowa Company, Ltd. | Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
-
1993
- 1993-09-28 WO PCT/US1993/009201 patent/WO1994007521A1/en active Application Filing
- 1993-09-28 AU AU52932/93A patent/AU5293293A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1994007521A1 (en) | 1994-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3738293A (en) | Compounds useful for treating allergic and inflammatory diseases | |
AU674894C (en) | Treatment of conditions and disease | |
AU6905391A (en) | Methods and compositions for the treatment of hodgkin's disease | |
AU6952896A (en) | Method for treatment of cancer and infectious diseases and compositions useful in same | |
AU6974996A (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
AU4214193A (en) | Bioadhesive treatment compositions and method of use | |
AU4028995A (en) | Antitumor compositions and methods of treatment | |
AU5287090A (en) | Method and composition for treatment of periodontal disease | |
HU9402817D0 (en) | Compounds for treating allergic and inflammatory diseases | |
AU2187992A (en) | Composition and method for disease treatment | |
SG44524A1 (en) | Methods and compositions of treating malaria and other diseases | |
AU5960394A (en) | Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases | |
AU8044491A (en) | Antitumor compositions and methods of treatment | |
AU5605398A (en) | Novel methods and compositions for treatment of autoimmune diseases | |
AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
AU2886292A (en) | Compositions and methods for treatment of epstein-barr virus-associated diseases | |
AU8192691A (en) | Method of treatment and compositions therefore | |
AU5293293A (en) | Methods and compositions for treatment of allergic disease | |
ZA971607B (en) | Methods of treatment of allergic diseases | |
AU3607597A (en) | Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases | |
AU4678893A (en) | Compositions and methods for topical treatment of skin lesions | |
GB2294637B (en) | Therapeutic compositions and methods of use | |
AUPM307793A0 (en) | Prophylaxis of allergic disease | |
AU4104093A (en) | Method and compositions for treatment of pyonecrotic processes | |
AU6366994A (en) | Methods for diagnosis and treatment of xscid |